Diabetes-Cardiorenal-Metabolic Medicine
Heart failure, chronic kidney disease and cardiovascular prevention as one connected system — reviewed against the 2026 ESC Heart Failure and ESC/ERA cardiovascular–kidney guidelines and the July 2026 CVD Modern Service Framework, with the NICE position you must use in the AKT.
Reviewed and kept current
Last editorial review: 28 September 2026 · Next scheduled refresh: March 2027.
The Golden Triangle for each topic taught here: fixed to the topic, and re-examined when its knowledge, evidence or real-world sources change.
Golden Triangle
Heart failure
Knowledge Green · Evidence Green · Real-world Red
Not yet at the Equinox · UK (NHS England) · as of 7 October 2026 · How the triangle works
Golden Triangle
Chronic kidney disease
Knowledge Green · Evidence Green · Real-world Red
Not yet at the Equinox · UK (NHS England) · as of 7 October 2026 · How the triangle works
Golden Triangle
Cardiovascular disease prevention
Knowledge Green · Evidence Green · Real-world Red
Not yet at the Equinox · UK (NHS England) · as of 7 October 2026 · How the triangle works
Diabetes-Cardiorenal-Metabolic Medicine
Heart failure, chronic kidney disease and cardiovascular prevention as one connected system — reviewed against the 2026 ESC Heart Failure and ESC/ERA cardiovascular–kidney guidelines and the July 2026 CVD Modern Service Framework, with the NICE position you must use in the AKT.
3 learning units
Work in order; each unit ends with its own certificate.
Heart failure in 2026: diagnosis, NT-proBNP and foundational therapy (ESC 2026 vs NICE)
Diagnose heart failure with NT-proBNP to NICE thresholds, start the four pillars of HFrEF therapy, and understand what the 2026 ESC guideline changed — including the removal of HFmrEF — and what the AKT still expects.
Open unitCKD in cardiovascular disease: ‘STAMP on CKD’ (ESC/ERA 2026) and NICE NG203
Test every patient with cardiovascular disease for CKD, classify by eGFR and ACR, refer by KFRE, and build the cardiorenal-protective regimen: RAS blockade, SGLT2 inhibitor, statin and, in type 2 diabetes, finerenone.
Open unitThe CVD Modern Service Framework (July 2026) and cardiovascular-kidney-metabolic prevention
What England’s first Modern Service Framework asks of general practice — finding the ‘missing millions’ and treating to target — with the NICE blood-pressure and lipid thresholds you need for the AKT.
Open unitDCRM Certificate of Advanced Studies
These units are free revision for the AKT. For credit-bearing, practice-changing depth in the same specialty, see MD Acumen’s Certificate of Advanced Studies.
View the programmeMRCGP AKT · CAS Programmes · For institutions · Legal & regulatory · enquiry@mdacumen.com
Educational content for healthcare professionals; apply clinical judgement and current local guidance. MRCGP is a registered trademark of the Royal College of General Practitioners. These units are independent, curriculum-aligned revision resources and are not endorsed by the RCGP.

© 2026 MD Acumen Ltd · Registered in England and Wales · Company no. 16538952 · ICO registration ZC105897